Clinical Kidney Journal

Article	Citations
Baseline proteinuria level and adverse outcomes in pregnant women with chronic kidney disease: new evidence and a note of caution	352
Single-nephron assessment of urate excretion in patients with IgA nephropathy	80
Early and late ANCA vasculitis relapses after kidney transplantation may have different presentations	77
Complement-activating conditions as potential triggers of pregnancy-related atypical haemolytic uraemic syndrome	66
Increase in the global burden of chronic kidney disease: might it be attributable to air pollution?	51
Rationale and design of CONTINUITY: a Phase 4 randomized controlled trial of continued post-discharge sodium zirconium cyclosilicate treatment versus standard of care for hyperkalemia in chronic kidne	48
Left-sided valvular heart disease in dialysis recipients: a single-centre observational study	46
Individualizing immunosuppressive therapy decision in immunoglobulin A nephropathy and application in a Southeast Asian cohort	38
Genetic evaluation of paediatric nephrocalcinosis: phenotype-driven genetic panels reveal a rare diagnosis	37
Estimating glomerular filtration rate with cystatin C: a systematic comparison of the new EKFC and the CKD-EPI equation	36
Loin pain haematuria syndrome 1967–2020: a review	35
Association between frailty and bone health in early-stage chronic kidney disease: a study from the population-based CARTaGENE cohort	34
Acute kidney injury after non-cardiac major surgery: has it reduced?	32
Life beyond Antibodies: Quality of Life after Desensitization in Kidney Transplantation	31
The predictive performance of the ANCA renal risk score in patients over 65 years of age with renal ANCA-associated vasculitis	31
Age- and time-dependent increases in incident anti-glomerular basement membrane disease: a nationwide cohort study	30
Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with onl	30
Cystatin C or creatinine for pre-operative assessment of kidney function and risk of post-operative acute kidney injury: a secondary analysis of the METS cohort study	27
New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: a multicohort observational study	27
Machine learning models for predicting acute kidney injury: a systematic review and critical appraisal	26
Efficacy and safety of telitacicept, a BLyS/APRIL dual inhibitor, in the treatment of IgA nephropathy: a retrospective case–control study	26
How to make a shared decision with older persons for end-stage kidney disease treatment: the added value of geronto-nephrology	26
Association of calciprotein particles with serum phosphorus among patients undergoing conventional and extended-hours haemodialysis	25
Development of a multimodal kidney age prediction based on automatic segmentation CT image in patients with normal renal function	24
The optimized anticoagulation strategy in prolonged hemodialysis	24

Relationship of serum lipid parameters with kidney function decline accompanied by systemic arterial stiffness: a retrospective cohort study	24
Reply to ‘Kidney involvement in hereditary transthyretin amyloidosis: is there a role for cystatin C?’	23
Plain language summary of a study looking at the effect of empagliflozin treatment in patients with chronic kidney disease	23
The dietary source of trimethylamine N-oxide and clinical outcomes: an unexpected liaison	23
Effect of serum creatinine difference between the Jaffe and the enzymatic method on kidney disease detection and staging	22
Monoclonal gammopathy of renal significance presenting with cryoglobulinaemia type I associated severe thrombotic microangiopathy	22
Clinicopathological prognostic stratification for proteinuria and kidney survival in IgA nephropathy: a Japanese prospective cohort study	21
Elimination and penetration of amikacin into urine in patients with decreased glomerular filtration rate	21
Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D	21
Changes in cardiac troponins during hemodialysis depend on hemodialysis membrane and modality: a randomized crossover trial	21
Fabry disease with atypical phenotype identified by massively parallel sequencing in early-onset kidney failure	21
Differentiating primary and secondary FSGS using non-invasive urine biomarkers	21
PLEX in AAV-GN: insights from the meta-analysis results and impact on remission induction treatment recommendations	20
2009 CKD-EPI glomerular filtration rate estimation in Black individuals outside the United States: a systematic review and meta-analysis	20
Focal segmental glomerulosclerosis associated with the use of the IL-23 inhibitor guselkumab	19
Non-contrast preoperative MRI for determining renal perfusion and visualizing renal arteries in potential living kidney donors at 1.5 Tesla	19
Gut-immune axis and cardiovascular risk in chronic kidney disease	19
Monoallelic pathogenic IFT140 variants are a common cause of autosomal dominant polycystic kidney disease–spectrum phenotype	19
Use of eHealth and remote patient monitoring: a tool to support home dialysis patients, with an emphasis on peritoneal dialysis	19
Comparison of different estimated glomerular filtration rates for monitoring of kidney function in oncology patients	19
Tofacitinib for the treatment of refractory immune checkpoint inhibitor-associated immune nephritis	18
Incidence of and risk factors of chronic kidney disease: results of a nationwide study in Iceland	18
Biomarkers in clinical epidemiology studies	18
Who killed Bruce Lee? The hyponatraemia hypothesis	18
Association of serum bicarbonate with the development of kidney stones in patients with chronic kidney disease: a retrospective cohort study	18
Hypoxia during maintenance hemodialysis—the critical role of pH	17
Sustained humoral response 6 months after the anti-SARS-CoV-2 mRNA-BNT162b2 vaccine in haemodialysis patients: should booster vaccine doses be given to all patients at the same time?	17
Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function	17
Correction to: Accelerated versus watchful waiting strategy of kidney replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized clinical trials	17
Welcome editorial by the new CKJ Editor-in-Chief: Facing the future of CKJ with enthusiasm!	17
31P-MRS, molecular level imaging for assessing muscular mitochondrial dysfunction in chronic kidney disease	16
Should we continue to use renin–angiotensin–aldosterone system blockers in patients with COVID-19?	16
Central volume shift in acute heart failure revealed by blood volume monitoring during haemodialysis	16
Moving on obesity treatment in CKD: inertia is unjustified	16
A phase IV, randomised, double-blind, controlled, parallel group trial to evaluate the effectiveness and safety of Balneum Plus versus emollient in the treatment of chronic kidney disease–associated p	16
Outcomes of primary membranous nephropathy refractory to immunosuppressants	16
Increased expression of SCARF genes favoring SARS-CoV-2 infection in key target organs in CKD	16
Exploring the impact and utility of genomic sequencing in established CKD	16
Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR	16
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study	16
Non-dilated obstructive nephropathy	15
Average creatinine–urea clearance: revival of an old analytical technique?	15
Tolvaptan and the role of kidney aquaporin-2 abundance in managing volume overload in patients with CKD	15
More dissimilarities than affinities between DNAJB11-PKD and ADPKD	15
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome	15
A pre-transplantation risk assessment tool for graft survival in Dutch pediatric kidney recipients	15
Remote digital urinalysis with smartphone technology as part of remote management of glomerular disease during the SARS-CoV-2 virus pandemic: single-centre experience in 25 patients	14
The place of cyclical therapy for the treatment of membranous nephropathy in the era of rituximab	14
The effect of parathyroid hormone lowering by etelcalcetide therapy on calcification propensity and calciprotein particles in hemodialysis patients	14
Recognition of intraglomerular histological features with deep learning in protocol transplant biopsies and their association with kidney function and prognosis	14

Qualitative approach to better understand the trajectory of patients with early and moderate stage CKD	14
Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria	14
Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients	14
Impact of peritoneal dialysis strategy on technique and patient survival	14
Effect of music therapy intervention on anxiety and pain during percutaneous renal biopsy: a randomized controlled trial	14
Impact of the COVID pandemic on vascular access creation for haemodialysis in 16 Spanish haemodialysis centres	14
Early growth response 1 as a podocyte injury marker in human glomerular diseases	14
Interaction of general obesity and abdominal obesity with frailty in patients with chronic kidney disease: a nationally representative analysis	14
Pharmacokinetic relevance of glomerular hyperfiltration for drug dosing	14
Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patients	14
Switching from immediate- to extended-release cysteamine in patients with nephropathic cystinosis: from clinical trials to clinical practice	13
The association of glucose metabolism and kidney function in middle-aged adults	13
Coturnism as a cause of deadly rhabdomyolysis in Biblical times	13
Can exercise improve outcomes for frail haemodialysis patients?	13
Regional variation in tolvaptan prescribing across England: national data and retrospective evaluation from an expert centre	13
Functional megalin is expressed in renal cysts in a mouse model of adult polycystic kidney disease	13
Diminished and waning immunity to COVID-19 vaccination among hemodialysis patients in Israel: the case for a third vaccine dose	13
Baxter Physioneal, Extraneal, Nutrineal (PEN) and Dianeal solution bags can be accidentally connected to Fresenius peritoneal dialysis catheter extensions in a non-sterile manner	13
Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis	12
Kynurenine pathway metabolites predict subclinical atherosclerotic disease and new cardiovascular events in chronic kidney disease	12
The effects of a physical exercise program in Chinese kidney transplant recipients: a prospective randomised controlled trial	12
The hypokalaemia that came from the cold	12
Recovery from kidney failure associated with chronic thromboembolic pulmonary hypertension following pulmonary thomboendarterectomy	12
The incidence of cancer recurrence and new cancer following commencement of dialysis	12
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study	12
Risk of incident chronic kidney disease among patients with urolithiasis: a nationwide longitudinal cohort study	12
The impact of mild and moderate COVID-19 infection on the progression of kidney dysfunction in patients with IgA nephropathy	12
Frailty assessment as part of transplant listing: yes, no or maybe?	12
Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies	12
Flank pain has a significant adverse impact on quality of life in ADPKD: the CYSTic-QoL study	11
The use of plasma biomarker-derived clusters for clinicopathologic phenotyping: results from the Boston Kidney Biopsy Cohort	11
Challenges of defining renal response in ANCA-associated vasculitis: call to action?	11
Meet and greet but avoid the heat: a reflection on the carbon footprint of congresses prompted by ERA2023	11
Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: an Italian multicenter prospective study	11
Peritoneal dialysis for acute kidney injury: back on the front-line	11
Association of metabolic acidosis with fractures, falls, protein-calorie malnutrition and failure to thrive in patients with chronic kidney disease	11
Acute kidney injury with hypernatremia and major adverse kidney events	11
Correction of profound hyponatremia following rapid bolus therapy: effectiveness of the barsoum–levine formula based on the edelman equation	11
The need for better donor engagement and outreach with legacy living kidney donors	11
Increased mortality after kidney transplantation in mildly frail recipients	11
Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective	11
Kidney glomerular filtration rate plasticity after transplantation	11
Associations of MRI-derived kidney volume, kidney function, body composition and physical performance in ≈38 000 UK Biobank participants: a population-based observational study	11
Effects of spironolactone on intradialytic hypertension: a multi-center, double-blind, randomized, crossover study	11
Non-invasive assessment of IgA nephropathy severity with [18F]AlF-NOTA-FAPI-04 PET/CT imaging	10
Robot-assisted kidney transplantation: an update	10
Management of de novo nephrolithiasis after kidney transplantation: a comprehensive review from the European Renal Association CKD-MBD working group	10
GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art	10
Kidney health for all: bridging the gap in kidney health education and literacy	10
Combined evaluation of glomerular phospholipase A2 receptor and immunoglobulin G subclass in membranous nephropathy	10
The hidden diabetic kidney disease in a university hospital-based population: a real-world data analysis	10
RICORS2040: the need for collaborative research in chronic kidney disease	10
A deep learning system for retinal vessel calibre improves cardiovascular risk prediction in Asians with chronic kidney disease	10
Serum bilirubin and kidney function: a Mendelian randomization study	10
Short-term peritoneal rest reduces peritoneal solute transport rate and increases ultrafiltration in high/high average transport peritoneal dialysis patients: a crossover randomized controlled trial	10
Urinary angiotensin-converting enzyme 2 and metabolomics in COVID-19-mediated kidney injury	10
Novel somatic PBX1 mosaicism likely masking syndromic CAKUT in an adult with bilateral kidney hypoplasia	10
The use of SGLT2 inhibitors and GLP-1 receptor agonists in older patients: a debate on approaches in CKD and non-CKD populations	10
From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes	10
Intravenous amino acid for kidney protection: current understanding and future perspectives	10
Serum anti-CRP antibodies differentiate etiology and predict relapse in acute tubulointerstitial nephritis	10
Inverse association between serum chloride levels and the risk of atrial fibrillation in chronic kidney disease patients	10
Cancer among kidney transplant recipients >20 years after transplantation: post-transplant lymphoproliferative disorder remains the most common cancer type in the ultra long-term	10
Systematic reporting of medical kidney biopsies	10
Push toward pre-emptive kidney transplantation – for sure?	10
Primary hyperoxaluria: the adult nephrologist's point of view	10
Vitamin D therapy in chronic kidney disease: a critical appraisal of clinical trial evidence	9
Association between magnesium, erythropoietin resistance and mortality: the Japanese Dialysis Outcomes and Practice Patterns Study (J-DOPPS)	9
Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia	9
Microemboli induced by air bubbles may be deposited in organs as a consequence of contamination during medical care	9
A real-world study on SGLT2 inhibitors and diabetic kidney disease progression	9
Increased 1-year mortality in haemodialysis patients with COVID-19: a prospective, observational study	9
Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?	9
Modified creatinine index as a marker of skeletal muscle mass in peritoneal dialysis patients	9
Pathogenic heterozygous TRPM7 variants and hypomagnesemia with developmental delay	9
Diuretic prescriptions in the first year of haemodialysis: international practice patterns and associations with outcomes	9
Measures of wave intensity as a non-invasive surrogate for cardiac function predicts mortality in haemodialysis patients	9
The role of genomic disorders in chronic kidney failure of undetermined aetiology ≤50 years	9
Urine metabolite changes after cardiac surgery predict acute kidney injury	9
The ERA Registry Annual Report 2020: a summary	9

Klotho and lean mass as novel cardiovascular risk factors in hemodialysis patients	9
EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors	9
Sex and gender differences in health-related quality of life in individuals treated with incremental and conventional hemodialysis	9
Unraveling complexity: morbidity factors in elderly kidney transplant recipients	9
Searching in the maze: sodium–glucose cotransporter-2 inhibitors in kidney transplant recipients to improve survival	9
Kidney transplantation and gut microbiota	9
Toward acid- and heparin-free dialysis: the regional anticoagulation approach	9
Mortality and disability-adjusted life years in North Africa and Middle East attributed to kidney dysfunction: a systematic analysis for the Global Burden of Disease Study 2019	9
Investigating the global prevalence and consequences of undiagnosed stage 3 chronic kidney disease: methods and rationale for the REVEAL-CKD study	9
Achieving consensus on psychosocial and physical rehabilitation management for people living with kidney disease	9
Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy	9
Kidney function and bone mineral density in chronic kidney disease patients	9
Compound heterozygous variants of ANKFY1 in a child with infantile-onset proteinuria and movement disorder	9
Urine complement-related proteins in IgA nephropathy and IgA vasculitis nephritis, possible biomarkers of disease activity	8
Successful treatment of calciphylaxis with vitamin K in a patient on haemodialysis	8
Management of acute renal replacement therapy in critically ill cirrhotic patients	8
The coexistence of diabetic retinopathy and diabetic nephropathy is associated with worse kidney outcomes	8
Thiazides in chronic kidney disease: “back to the future”	8
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus	8
[18F] AlF-NOTA-FAPI-04 PET/CT for non-invasive assessment of tubular injury in kidney diseases	8
Developing a patient-centred tool for pain measurement and evaluation in autosomal dominant polycystic kidney disease	8
CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and kidney dysfunction	8
Urinary RANTES and MCP-1 as noninvasive biomarkers for differential diagnosis and prediction of treatment response in acute interstitial nephritis	8
Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic	8
Breaking barriers: giving HOPE to people living with HIV and end-stage renal disease	8
Point-of-care ultrasound training in nephrology: a position statement by the International Alliance for POCUS in Nephrology	8
A puzzling renal Fanconi Syndrome	8
Primary hyperoxaluria type 1: pathophysiology and genetics	8
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease	8
Application of artificial intelligence to chronic kidney disease mineral bone disorder	8
Management of fracture risk in CKD—traditional and novel approaches	8
An introduction to inverse probability of treatment weighting in observational research	8
Estimating glomerular filtration in young people	8
Bidirectional association of sleep disorders with chronic kidney disease: a systematic review and meta-analysis	8
GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity	8
Risk factors for acute kidney injury and kidney relapse in patients with lupus podocytopathy	8
Pre-emptive use of glucose 5% as the standard drug solvent reduces hypernatremia in critically ill patients	8
Development and validation of a measure to assess patient experience of needling of arteriovenous fistulas or grafts for haemodialysis access: the NPREM	8
Risk factors for steroid-induced osteonecrosis of the femoral head in children with immune kidney disease	8
Clinically Meaningful eGFR Slope as a Surrogate Endpoint Differs across CKD Stages and Slope Evaluation Periods: the CKD-JAC Study	8
Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression—real-world clinical practice	8
Histologic characterization and risk factors for persistent albuminuria in adolescents in a region of highly prevalent end-stage renal failure of unknown origin	8
The kidney in hantavirus infection—epidemiology, virology, pathophysiology, clinical presentation, diagnosis and management	8
Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey	8
Mission P(D)-ossible- peritoneal dialysis in difficult cases	8
The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patient	8
Multitargeted interventions to reduce dialysis-induced systemic stress	8
First case of atypical haemolytic uraemic syndrome following COVID-19 vaccination with BNT162b2	8
Informal caregiver burden in dialysis care and how it relates to patients’ health-related quality of life and symptoms	8
Cerebral blood flow following successful living kidney transplantation: the VINTAGE study	8
Ten tips on how to manage obesity in the presence of CKD	8
Correcting hyponatremia is associated with improve survival in hyponatremic metastatic cancer patients	8
Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: the Spanish COVID-19 KRT Registry	7
Short-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine	7
Farewell from the CKJ Editor-in-Chief: key kidney topics from 2014 to 2021	7
Management of post-transplant diabetes mellitus: an opportunity for novel therapeutics	7
Mediators of the association between albuminuria and incident cancer: the PREVEND study	7
Early glomerular filtration rate changes in living kidney donors and recipients: an example of renal plasticity	7
Does kidney transplantation influence a form of discrimination for antihypertensive drugs prescriptions?	7
Excessive risk and poor outcome of hospital-acquired peritoneal dialysis-related peritonitis	7
Sodium–glucose cotransporter 2 inhibitors: renal outcomes according to baseline albuminuria	7
Integrating electronic health data records to develop and validate a predictive model of hospital-acquired acute kidney injury in non-critically ill patients	7
A new methodological series in CKJ: from basic-level methodology to artificial intelligence in medicine	7
Tirzepatide and prevention of chronic kidney disease	7
Gain-of-function TLR7 and loss-of-function A20 gene variants identify a novel pathway for Mendelian lupus and lupus nephritis	7
Calcium polystyrene sulfonate–induced colitis: advanced characterization of crystal nature with infrared spectroscopy	7
Novel loss-of-function mutations in TNFAIP3 gene in patients with lupus nephritis	7
Dealing with an uncertain future: a survey study on what patients with chronic kidney disease actually want to know	7
Prevalence and outcomes of chronic liver disease in patients receiving dialysis: systematic review and meta-analysis	7
Cardiovascular, renal and mortality risk by the KDIGO heatmap in Japan	7
Kidney function–specific cut-off values of high-sensitivity cardiac troponin T for the diagnosis of acute myocardial infarction	7
Oral glucocorticoids with intravenous cyclophosphamide or oral glucocorticoids alone in the treatment of IgA nephropathy present with nephrotic syndrome and mesangioproliferative glomerulonephritis	7
Circulating Omentin-1 levels and altered iron balance in chronic haemodialysis patients	7
Comparison of four medium cut-off dialyzers	7
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients	7
Pharmacological strategies to manage hyperkalaemia: out with the old, in with the new? Not so fast…	7
Pseudo-AKI associated with targeted anti-cancer agents—the truth is in the eye of the filtration marker	7
The integrated care model: facilitating initiation of or transition to home dialysis	7
Effect of ultrafiltration on cerebral small-vessel disease and related outcomes in hemodialysis	6
Performances of acute kidney injury biomarkers vary according to sex	6
Venous bicarbonate and CKD progression: a longitudinal analysis by the group-based trajectory model	6
Genome editing and kidney health	6
Multiparametric magnetic resonance imaging allows non-invasive functional and structural evaluation of diabetic kidney disease	6
Genetic and clinical characterization of familial renal glucosuria	6
Donor liquid biopsy and outcomes in kidney transplantation	6
Clinical and pathological characteristics in elderly patients with IgA nephropathy	6
Association between beta-blocker utilization and heart failure mortality in the peritoneal dialysis population: a cohort study	6
Deciphering three predominant biopsy-proven phenotypes of IgG4-associated kidney disease: a retrospective study	6
Donor obesity and weight gain after transplantation: two still overlooked threats to long-term graft survival	6
Glomerular endothelial injury following vaccination for SARS-CoV-2	6
Native BK virus nephropathy in lung transplant: a case report and literature review	6
Urinary peptidome analysis in CKD and IgA nephropathy	6
Comparison of safety and outcomes related to remdesivir treatment among dialysis patients hospitalized with COVID-19	6
Podocyturia in Fabry disease: a 10-year follow-up	6
Treatment practices and outcomes in incident peritoneal dialysis patients: the Swedish Renal Registry 2006–2015	6